IMGN Financial Facts

General and administrative: 9.3M
Clinical materials reimbursement: 53K
See Full Income Statement

Total liabilities and shareholders' equity: 287.09M
Other assets: 3.43M
See Full Balance Sheet

Immunogen Inc. (IMGN) Earnings

  |   Expand Research on IMGN
Next EPS Date 1/30/17 *Est. EPS Growth Rate -30.8% *Last Qtr.
Average EPS % Beat Rate -21.5% Revenue Growth Rate -48.6% *Last Qtr.
Average % Move 1-Wk after EPS -9.6% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/28/16 Q117 -$0.51-$0.38 -$0.13$7.66M$21.12M N/A Details
8/4/16 Q416 -$0.51-$0.39 -$0.12$7.41M$17.11M N/A Details
4/29/16 Q316 -$0.37-$0.32 -$0.05$19.7M$23.02M N/A Details
1/29/16 Q216 -$0.38-$0.36 -$0.02N/A$17.87M N/A Details
10/27/15 Q116 -$0.39-$0.35 -$0.04$14.9M$15.84M N/A Details
7/31/15 Q415 -$0.71-$0.35 -$0.36$12.61M$15.42M N/A Details
4/24/15 Q315 -$0.25-$0.24 -$0.01$11.4M$20.95M N/A Details
1/30/15 Q215 $0.16-$0.05 +$0.21$48.3M$37.3M N/A Details